Newsbenzinga
Abbott CEO Rules Out Selling $8.5 Billion Nutrition Business: 'No Interest'
· Published
Article summary
Abbott (ABT) to spin off its $8.5B nutrition arm, makers of Ensure & Similac, by end of 2027. Stock dips following Q3 results.
An excerpt from the original article.
Comments —
Loading comments…